BENJAMIN WARE: Open Payments
NPI 1073048575 · ASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,581 in 194 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $2,926 · 2025 $3,581
Food & beverage: $3,581
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $399 |
| AstraZeneca Pharmaceuticals LP | 15 | $300 |
| GlaxoSmithKline, LLC. | 13 | $298 |
| Novo Nordisk Inc | 14 | $260 |
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| ABBVIE INC. | 14 | $206 |
| Exact Sciences Corporation | 11 | $188 |
| Astellas Pharma US Inc | 10 | $148 |
| Axsome Therapeutics, Inc. | 6 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $143 |
Products named: REXULTI, TRELEGY ELLIPTA, ELIQUIS, Wegovy, BREZTRI, PREVNAR 20, Veozah, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
